Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT03136133
Eligibility Criteria:
Inclusion Criteria:
* Signed informed Consent
* The subject is a man between 40-50 years
* The subject has a body mass index (BMI) between 19-29
* Willing to comply with all study procedures and be available for the length of the study
* In good general health as judged by the physician at the screening visit
Exclusion Criteria:
* The subject has had surgery or trauma with significant blood loss or has donated blood within the last 3 months prior to the screening visit
* Diabetes type 1 or 2, or persistent high blood sugar levels
* The subject has tested positive for human immunodeficiency virus (HIV)
* Hepatitis B surface antigen (HBsAg), or hepatitis C virus antibody (anti-HCV)
* The subject has taken any investigational drugs within 1 month prior to screening
* Treated with antibiotics within 3 months prior to screening (oral, parenteral or rectal), but not spray or ointment
* Treated with steroids within 1 month prior to screening (including oral treatment)
* Treated with medication that effects the intestinal function such as, H2- protonpump inhibitors, diuretics, antiemetics, antidepressants, antacids,
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
50 Years
Study:
NCT03136133
Study Brief:
Protocol Section:
NCT03136133